Related Experiment Videos

Molecular mechanisms of ginsenoside Rp1-mediated growth arrest and apoptosis

Ashok Kumar1, Madhu Kumar, Tae-Yoon Park

  • 1Radiation and Cancer Biology Lab, University of Rajasthan, Jaipur, India.

International Journal of Molecular Medicine
|July 30, 2009
PubMed

Insights

Ginsenoside Rp1 inhibits HeLa cell proliferation by causing G1 phase arrest and apoptosis. This ginseng saponin modulates cell cycle proteins and activates caspases, leading to programmed cell death.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Biochemistry

Background:

  • Ginsenoside Rp1, a semi-synthesized ginseng saponin, exhibits chemopreventive and anti-metastatic properties.
  • The precise molecular mechanisms underlying Rp1's effects on cell growth and death remain incompletely elucidated.

Purpose of the Study:

  • To investigate the antiproliferative effects of Ginsenoside Rp1 on HeLa cells in vitro.
  • To elucidate the molecular pathways involved in Rp1-induced cell cycle arrest and apoptosis.

Main Methods:

  • HeLa cells were treated with 40 microM Ginsenoside Rp1.
  • Cell cycle progression was analyzed using flow cytometry.
  • Expression levels of key cell cycle regulatory proteins (cyclins, p21, p53) were assessed.
  • Apoptosis was evaluated by measuring caspase activation (caspase-3, -8, -9), poly(ADP-ribose) polymerase (PARP) cleavage, and mitochondrial cytochrome c release.
  • The role of Bcl-2 family proteins (Bad, Bax, Bid, Bcl-2) was examined.

Main Results:

  • Rp1 treatment resulted in G1 phase cell cycle arrest, characterized by decreased cyclin D1, E, and A expression and increased p21 levels.
  • Prolonged Rp1 exposure induced apoptosis, evidenced by the activation of caspase-3, -8, and -9, and PARP cleavage.
  • Rp1 activated Bax and Bid, leading to mitochondrial release of cytochrome c and subsequent caspase-9 activation.
  • Inhibitor studies confirmed the critical role of caspases in Rp1-induced apoptosis.

Conclusions:

  • Ginsenoside Rp1 effectively inhibits HeLa cell proliferation through G1 cell cycle arrest and apoptosis induction.
  • Rp1 modulates critical cell cycle regulators and activates the intrinsic and extrinsic apoptotic pathways via caspase cascades.
  • These findings highlight Rp1's potential as an anticancer agent by targeting multiple cellular processes.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...